Engrave Wealth Partners LLC Abb Vie Inc. Transaction History
Engrave Wealth Partners LLC
- $350 Million
- Q4 2023
A detailed history of Engrave Wealth Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Engrave Wealth Partners LLC holds 1,481 shares of ABBV stock, worth $281,597. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,481
Previous 1,447
2.35%
Holding current value
$281,597
Previous $215,000
6.51%
% of portfolio
0.07%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
3,894Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$32.6 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.95 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.36 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $336B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...